Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1 West First Avenue CONSHOHOCKEN PA 19428 |
Tel: | 1-610-727-3693 |
Website: | https://www.cencora.com |
IR: | See website |
Key People | ||
Steven H. Collis Chairman of the Board, President, Chief Executive Officer | James F. Cleary Chief Financial Officer, Executive Vice President | Robert P. Mauch Chief Operating Officer, Executive Vice President |
Silvana Battaglia Chief Human Resource Officer, Executive Vice President | Gina K. Clark Executive Vice President, Chief Communications and Administration Officer | Elizabeth S. Campbell Executive Vice President and Chief Legal Officer | Leslie E. Donato Executive Vice President and Chief Strategy Officer |
Business Overview |
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. |
Financial Overview |
For the three months ended 31 December 2023, Cencora Inc revenues increased 15% to $72.25B. Net income increased 25% to $601.5M. Revenues reflect Human Health segment increase of 16% to $63.9B, Alliance Healthcare segment increase of 5% to $5.73B, Other Healthcare Solutions segment increase of 17% to $1.34B. Net income benefited from U.S. Healthcare Solutions segment income increase of 22% to $698.1M. |
Employees: | 42,000 as of Sep 30, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $50,341M as of Dec 31, 2023 |
Annual revenue (TTM): | $271,579M as of Dec 31, 2023 |
EBITDA (TTM): | $3,749M as of Dec 31, 2023 |
Net annual income (TTM): | $1,867M as of Dec 31, 2023 |
Free cash flow (TTM): | $3,225M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1,906M as of Dec 31, 2023 |
Shares outstanding: | 199,481,993 as of Jan 29, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |